2021-06-01 13:30:36 GMT2021-06-01 21:30:36(Beijing Time) Xinhua English
LUSAKA, June 1 (Xinhua) Zambia has approved five COVID-19 vaccines to be administered on citizens as a preventive measure against the pandemic, a government official said on Tuesday.
The vaccines include China s Sinopharm, Johnson & Johnson, AstraZeneca Covishield, AZD 12225-Korea AstraZeneca, and Pfizer Biotech.
Kennedy Malama, Permanent Secretary in the Ministry of Health in charge of Technical Services, said the five vaccines have been approved by the country s medicines regulator, the Zambia Medicines Regulatory Authority (ZAMRA), following stringent review processes and riding on the World Health Organization emergency use listing of the vaccines.
ZAMRA APPROVES 5 COVID-19 VACCINES FOR ZAMBIA
zambiareports.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zambiareports.com Daily Mail and Mail on Sunday newspapers.
Zambia approves 5 COVID-19 vaccines
shanghaisun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from shanghaisun.com Daily Mail and Mail on Sunday newspapers.
Central Province Health Director (PHD), Kennedy Kabuswe, confirmed this development
Dr Kabuswe said the launch of the COVID 19 vaccination will be held at Kabwe Women, New-born and Children’s Hospital tomorrow.
He said the function will be graced by the Central Province Provincial Administration and will be attended by all stakeholders in Kabwe.
He added that health workers have already been trained by experts from the Zambia Medicines Regulatory Authority (ZAMRA) and the Ministry of Health (MOH) ahead of the roll-out.
“The province is ready to roll-out the COVID 19 vaccinations. Experts from the Ministry of Health (MOH) and ZAMRA were in the province to train health workers from all the districts,” Dr Kabuswe said.
THE Zambia Medicines Regulatory Authority (ZAMRA) and Zambia Medicines and Medical Supplies Agency (ZMMSA) have denied exposing citizens to substandard medicines and medical supplies through failure to perform their statutory duties. ZAMRA and ZMMSA have further denied the claims by Chapter One Foundation Limited that they failed or neglected to ensure that the public was provided with accurate description of all recalled substandard medicines and medical supplies procured from Honeybee Pharmaceuticals. ZMMSA has argued that the said information was provided to the entities which required to be notified by law..
To continue reading this premium content, login to your account or Subscribe to our ePaper using the buttons below.